To determine if peripheral angiotensin II (Ang II) prejunctional receptors facilitating NE release exist in humans, we used [3H]NE kinetic methodology to measure forearm NE spillover during intrabrachial arterial Ang II infusions in eight normal male subjects. We used the following protocol to optimize conditions for demonstrating these receptors: (a) lower body negative pressure (-15 mmHg) to increase sympathetic nerve activity to skeletal muscle; and (b) intraarterial nitroprusside to maintain a high constant forearm blood flow (approximately 10 ml/min.100 ml) to maximize the proportion of neuronally released NE that spills over into the circulation. During lower body negative pressure, the following were infused intraarterially for three consecutive 20-min periods: saline, Ang II (4 ng/min), and Ang II (16 ng/min). During the Ang II infusions, forearm venous NE increased significantly from 173 to 189 and 224 pg/ml (P < 0.01), and forearm NE spillover increased from 384 to 439 and 560 ng/min.100 ml (P < 0.05 for high Ang II). Forearm NE clearance was unchanged. During low and high dose Ang II, the plasma venous Ang II concentrations were 25 and 97 pM, respectively. Since normal subjects increase plasma Ang II from 4 to 20-22 pM with exercise, standing, or diuretic administration, and patients with severe congestive heart failure can have a plasma Ang II of approximately 25 pM at rest, we suggest that Ang II might facilitate NE release in severe congestive heart failure, especially under conditions of stress.
B Clemson, L Gaul, S S Gubin, D M Campsey, J McConville, J Nussberger, R Zelis
Title and authors | Publication | Year |
---|---|---|
Hypertension increases sympathetic neuron activity by enhancing intraganglionic cholinergic collateral connections
Li M, Sorensen M, Johnson MA, Ingram SL, Andresen MC, Habecker BA |
The Journal of physiology | 2024 |
The autonomic nervous system and ventricular arrhythmias in myocardial infarction and heart failure
P Wu, M Vaseghi |
Pacing and clinical electrophysiology : PACE | 2020 |
Sympathetic Denervation for Treatment of Ventricular Arrhythmias
D Lakkireddy |
Journal of atrial fibrillation | 2020 |
Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF
S Prausmüller, H Arfsten, G Spinka, C Freitag, PE Bartko, G Goliasch, G Strunk, N Pavo, M Hülsmann |
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease | 2020 |
Angiotensin II in Vasodilatory Shock
BJ Wakefield, LW Busse, AK Khanna |
Critical Care Clinics | 2019 |
Angiotensin II Regulates Excitability and Contractile Functions of Myocardium and Smooth Muscles through Autonomic Nervous Transmission
F Yamaki, K Obara, Y Tanaka |
YAKUGAKU ZASSHI | 2019 |
Effect of Salt Supplementation on Sympathetic Activity and Endothelial Function in Salt-Sensitive Type 2 Diabetes
S Baqar, YW Kong, AX Chen, C OCallaghan, RJ MacIsaac, M Bouterakos, GW Lambert, G Jerums, EE Lambert, EI Ekinci |
The Journal of clinical endocrinology and metabolism | 2019 |
Age-Related Differences in the Cutaneous Vascular Response to Exogenous Angiotensin II
JA Lang, AC Krajek |
American journal of physiology. Heart and circulatory physiology | 2018 |
The effect of angiotensin II on blood pressure in patients with circulatory shock: a structured review of the literature
LW Busse, MT McCurdy, O Ali, A Hall, H Chen, M Ostermann |
Critical Care | 2017 |
Acute effects of angiotensin-converting enzyme inhibition versus angiotensin II receptor blockade on cardiac sympathetic activity in patients with heart failure
ER Azevedo, S Mak, JS Floras, JD Parker |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2017 |
Effect of heart failure on catecholamine granule morphology and storage in chromaffin cells
SK Mahata, H Zheng, S Mahata, X Liu, KP Patel |
Journal of Endocrinology | 2016 |
‘Fine-tuning’ blood flow to the exercising muscle with advancing age: an update: Exercise hyperaemia in the elderly
DW Wray, RS Richardson |
Experimental Physiology | 2015 |
Can intradermal administration of angiotensin II influence human heat loss responses during whole body heat stress?
N Fujii, RD Meade, G Paull, R McGinn, I Foudil-bey, P Akbari, GP Kenny |
Journal of applied physiology | 2015 |
Angiotensin II type I receptor blockade attenuates reflex cutaneous vasoconstriction in aged but not young skin
JA Lang, KE Kolb |
American journal of physiology. Heart and circulatory physiology | 2015 |
The Clinical Usefulness of Cardiac Sympathetic Nerve Imaging using 123Iodine-Meta-iodobenzylguanidine Scintigraphy to Evaluate the Effectiveness of Pharmacological Treatments in Patients with Heart Failure
S Kasama, T Toyama, M Kurabayashi |
2015 | |
Comprehensive Physiology
SN Cheuvront, RW Kenefick |
Comprehensive Physiology | 2014 |
Adrenergic and non-adrenergic control of active skeletal muscle blood flow: Implications for blood pressure regulation during exercise
SW Holwerda, RM Restaino, PJ Fadel |
Autonomic Neuroscience | 2014 |
Angiotensin II, sympathetic nerve activity and chronic heart failure
Y Wang, SW Seto, J Golledge |
Heart Failure Reviews | 2012 |
Angiotensin II potentiates α-adrenergic vasoconstriction in the elderly
Z Barrett‑O’Keefe, MA Witman, J Mcdaniel, AS Fjeldstad, JD Trinity, SJ Ives, JD Conklin, V Reese, S Runnels, DE Morgan, M Sander, RS Richardson, DW Wray |
Clinical Science | 2012 |
Reflex systemic sympatho-neural response to brachial adenosine infusion in treated heart failure
HC Wijeysundera, G Parmar, GA Rongen, JS Floras |
European Journal of Heart Failure | 2011 |
Angiotensinergic and noradrenergic neurons in the rat and human heart
J Patil, S Stucki, J Nussberger, T Schaffner, S Gygax, J Bohlender, H Imboden |
Regulatory Peptides | 2011 |
Heart Failure: A Companion to Braunwald's Heart Disease
A Diwan, GW Dorn |
Heart Failure: A Companion to Braunwald's Heart Disease | 2011 |
Intradermal angiotensin II administration attenuates the local cutaneous vasodilator heating response
JM Stewart, I Taneja, N Raghunath, D Clarke, MS Medow |
American journal of physiology. Heart and circulatory physiology | 2008 |
Angiotensin II type 1 receptor blockade corrects cutaneous nitric oxide deficit in postural tachycardia syndrome
JM Stewart, I Taneja, J Glover, MS Medow |
American journal of physiology. Heart and circulatory physiology | 2007 |
Direct regulation of insulin secretion by angiotensin II in human islets of Langerhans
RD Ramracheya, DS Muller, Y Wu, BJ Whitehouse, GC Huang, SA Amiel, J Karalliedde, G Viberti, PM Jones, SJ Persaud |
Diabetologia | 2006 |
Exercise-induced inhibition of angiotensin II vasoconstriction in human thigh muscle: Angiotensin II effects during exercise
RM Brothers, ML Haslund, DW Wray, PB Raven, M Sander |
The Journal of Physiology | 2006 |
Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension
H Krum, E Lambert, E Windebank, DJ Campbell, M Esler |
American journal of physiology. Heart and circulatory physiology | 2006 |
Angiotensin II and norepinephrine release: interaction and effects on the heart
MP Schlaich, DM Kaye, E Lambert, J Hastings, DJ Campbell, G Lambert, MD Esler |
Journal of Hypertension | 2005 |
Pressor and intra-renal effects of angiotensins I and II, and noradrenaline, in anaesthetized and conscious sheep
AJ Duckworth, AE Goodship, HJ Kendall, EC Osborn |
Medical Hypotheses | 2005 |
Protective Effects of an Angiotensin II Receptor Blocker and a Long-Acting Calcium Channel Blocker against Cardiovascular Organ Injuries in Hypertensive Patients
T ISHIMITSU, T KOBAYASHI, T HONDA, M TAKAHASHI, J MINAMI, S OHTA, H INADA, M YOSHII, H ONO, H MATSUOKA |
Hypertension Research | 2005 |
Changes in cyclic nucleotide phosphodiesterase activity and calmodulin concentration in heart muscle of cardiomyopathic hamsters
R Masunaga, A Nagasaka, Y Sawai, N Hayakawa, A Nakai, K Hotta, Y Kato, H Hishida, H Takahashi, M Naka, Y Shimada, T Tanaka, H Hidaka, M Itoh |
Journal of Molecular and Cellular Cardiology | 2004 |
Regulation of the Catecholamine β-Adrenergic System in Ventricular Remodeling of Hypertension
P Yingxin, S Jiang, Q Xiaoyong, X Hao, R Chunli, Y Dongmei, G Zhiqin, Z Shiling, W Min |
Japanese Heart Journal | 2004 |
Interactions between the sympathetic nervous system and the RAAS in heart failure
SR Goldsmith |
Current Heart Failure Reports | 2004 |
Angiotensin Vol. I
T Unger, BA Schölkens |
2004 | |
Myocardial perfusion in type 2 diabetes with left ventricular hypertrophy: normalisation by acute angiotensin-converting enzyme inhibition
B Hesse, C Meyer, FS Nielsen, A Sato, JD Hove, S Holm, LE Bang, KF Kofoed, TL Svendsen, HH Parving, LH Opie |
European Journal of Nuclear Medicine and Molecular Imaging | 2004 |
Modulation of angiotensin II responses in sympathetic neurons by cytosolic calcium
SF Fernandez, MH Huang, BA Davidson, PR 3rd, JL Izzo |
Hypertension | 2003 |
Effects of the AT1-receptor antagonist eprosartan on the progression of left ventricular dysfunction in dogs with heart failure
G Suzuki, T Mishima, EJ Tanhehco, VG Sharov, A Todor, S Rostogi, RC Gupta, PA Chaudhry, PV Anagnostopoulos, O Nass, S Goldstein, HN Sabbah |
British Journal of Pharmacology | 2003 |
Effects of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Type 1 Receptor Blockade on β-Adrenoceptor Signaling in Heart Failure Produced by Myocardial Infarction in Rabbits: Reversal of Altered Expression of β-Adrenoceptor Kinase and G iα
T Makino, Y Hattori, N Matsuda, H Onozuka, I Sakuma, A Kitabatake |
The Journal of pharmacology and experimental therapeutics | 2003 |
Autonomic effects of vasoactive drugs: physiological insights and clinical implications
R Wolk, VK Somers |
Journal of Hypertension | 2002 |
Prejunctional modulation of sympathetic tone by angiotensin II receptor antagonists: are there relevant differences?
W Kiowski |
Journal of Hypertension | 2002 |
Cardiac autonomic tone during trandolapril-irbesartan low-dose combined therapy in hypertension: a pilot project
F Franchi, C Lazzeri, M Foschi, C Tosti-Guerra, G Barletta |
Journal of Human Hypertension | 2002 |
Exogenous Angiotensin II Does Not Facilitate Norepinephrine Release in the Heart
TW Lameris, S de Zeeuw, DJ Duncker, G Alberts, F Boomsma, PD Verdouw, AH van den Meiracker |
Hypertension | 2002 |
Differentiation in the Angiotensin II Receptor 1 blocker class on autonomic function
H Krum |
Current Hypertension Reports | 2001 |
Increased vasoconstrictor sensitivity in obstructive sleep apnea
H Kraiczi, J Hedner, Y Peker, J Carlson |
Journal of applied physiology | 2000 |
Norepinephrine turnover in peripheral tissues of rats with heart failure
KP Patel, K Zhang, PK Carmines |
American Journal of Physiology - Regulatory, Integrative and Comparative Physiology | 2000 |
β-Blockade Prevents Sustained Metalloproteinase Activation and Diastolic Stiffening Induced by Angiotensin II Combined With Evolving Cardiac Dysfunction
H Senzaki, N Paolocci, YA Gluzband, ML Lindsey, JS Janicki, MT Crow, DA Kass |
Circulation research | 2000 |
Angiotensin II--nitric oxide interactions in the control of sympathetic outflow in heart failure
I H Zucker, J L Liu |
Heart Failure Reviews | 2000 |
Angiotensin II and sympathoactivation in heart failure
SR Goldsmith |
Journal of Cardiac Failure | 1999 |
ARCTIC: Assessment of haemodynamic Response in patients with Congestive heart failure to Telmisartan: A multicentre dose-ranging study In Canada
AB Parker, ER Azevedo, MG Baird, SJ Smith, JM Arnold, DP Humen, GW Moe, JO Parker, RW Butt, JD Parker |
American Heart Journal | 1999 |
Angiotensin AT1 receptor blockade abolishes the reflex sympatho-excitatory response to adenosine
GA Rongen, SC Brooks, S Ando, BL Abramson, JS Floras |
Journal of Clinical Investigation | 1998 |
Effect of losartan on afferent nerve stimulation
C Damase-Michel, MA Tran, JL Montastruc, P Montastruc |
European Journal of Pharmacology | 1998 |
Regulation of regional norepinephrine spillover in heart failure: The effect of angiotensin ii and β-adrenergic agonists in the forearm circulation
SR Goldsmith, M Garr, M McLaurin |
Journal of Cardiac Failure | 1998 |
Regulation of peripheral vascular tone in patients with heart failure: contribution of angiotensin II
DE Newby, NE Goodfield, AD Flapan, NA Boon, KA Fox, DJ Webb |
Heart (British Cardiac Society) | 1998 |
Effect of standing on neurohumoral responses and plasma volume in healthy subjects
G Jacob, AC Ertl, JR Shannon, R Furlan, RM Robertson, D Robertson |
Journal of applied physiology | 1998 |
Neural and Hypotensive Effects of Angiotensin II Receptor Blockade
GA Rongen, SC Brooks, S Ando, HR Dajani, BL Abramson, JS Floras |
Hypertension | 1998 |
ACE Inhibition: Postsynaptic Adrenergic Sympatholytic Action in Men
D Lyons, S Roy, S OByrne, CG Swift |
Circulation | 1997 |
Angiotensin converting enzyme inhibition and sympathetic activity in healthy subjects*
CC Lang, CM Stein, HB He, AJ Wood |
Clinical Pharmacology & Therapeutics | 1996 |
Regulation of Norepinephrine Release by β2-Adrenergic Receptors during Halothane Anesthesia
R Deegan, HB He, Y Krivoruk, A Wood, M Wood |
Anesthesiology | 1995 |
Compartmental analysis of norepinephrine kinetics in congestive heart failure
L Stylos, L Parilak, MH Green, U Leuenberger, R Zelis |
The American Journal of Cardiology | 1995 |
Angiotensin II and Sympathetic Activity in Sodium-Restricted Essential Hypertension
S Taddei, A Virdis, P Mattei, S Favilla, A Salvetti |
Hypertension | 1995 |
Long-term Treatment With Angiotensin I–Converting Enzyme Inhibitors Attenuates the Loss of Cardiac β-Adrenoceptor Responses in Rats With Chronic Heart Failure
A Sanbe, S Takeo |
Circulation | 1995 |
Metabolic control of the circulation: Implications for congestive heart failure
JM Delehanty, C Liang |
Progress in Cardiovascular Diseases | 1995 |